Back to results
US 2021/0069356 A1Published application
Isotopologues of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide
AssigneeCelgene Corporation
InventorsJoshua Hansen, Weihong Zhang
Life of this patent
Estimating the term…
Abstract
Provided herein are isotopologues of Compound A, which are enriched with isotopes such as, for example, deuterium. Pharmaceutical compositions comprising the isotope-enriched compounds, and methods of using such compounds are also provided.
Claims22
A compound, wherein the compound is an isotopologue of a compound having the following structure:
- or a stereoisomer, a mixture of stereoisomers, a pharmaceutically acceptable salt, a tautomer, a solvate, a hydrate, a co-crystal, a clathrate, or a polymorph thereof.
22-30. (canceled)
Dependencies are inferred from the claim text.